Poltreg S.A. (WSE:PTG)

Poland flag Poland · Delayed Price · Currency is PLN
17.15
+0.15 (0.88%)
Apr 28, 2026, 5:00 PM CET
-51.55%
Market Cap 79.28M
Revenue (ttm) n/a
Net Income (ttm) -24.56M
Shares Out 4.66M
EPS (ttm) -5.27
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,163
Average Volume 8,173
Open 17.15
Previous Close 17.00
Day's Range 16.95 - 17.15
52-Week Range 16.00 - 37.30
Beta 0.98
RSI 35.60
Earnings Date Apr 15, 2026

About Poltreg

Poltreg S.A., a biotechnology company, researches and develops therapies for autoimmune diseases. It engages in the development of therapies for the treatment of type 1 diabetes in children, as well as multiple sclerosis. The company was incorporated in 2016 and is based in Gdańsk, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 33
Stock Exchange Warsaw Stock Exchange
Ticker Symbol PTG
Full Company Profile

Financial Performance

In 2024, Poltreg's revenue was 350,000, a decrease of -74.98% compared to the previous year's 1.40 million. Losses were -18.71 million, 38.1% more than in 2023.

Financial Statements

News

There is no news available yet.